Servier today announced that it will present updates from its research programs at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on May 30 – June 3 in Chicago....

The data shows the prognostic value of Foresight CLARITY MRD detection at the end of frontline DLBCL in one of its largest prospective, real-world studies to date Data will be presented as an oral...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focus on advanced or metastatic patients with BRCA-1 and/or BRCA-2-deficient breast cancer or MSI-H...

The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that Jim Crowley, Global Head of BNY Pershing, will speak at the Morgan Stanley...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Stifel 2025 Jaws & Paws Conference. The fireside chat will take place on Wednesday,...